Zepbound (tirzepatide) available in US pharmacies for adults living with obesity owenhaskins Dec 6, 2023 2 min read Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with a BMI of 30kg/m2 or greater) or those who are overweight (with a BMI of 27kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidaemia, type 2 diabetes mellitus, obstructive sleep apnoea or cardiovascular disease, to lose weight and keep it off
While GLP-1 medications have undoubtedly been life-changing for many people, theyre not without drawbacks
When a licensed 503A compounding pharmacy prepares semaglutide, they assign an expiration date based on stability data, ingredient quality, and container integrity
The actions of both of these naturally occurring hormones and the drugs that mimic them can make you feel fuller quicker and longer, which can curb appetite and help you lose weight
For decades, the profession has implicitly blamed owners for fat pets
No bellwether trial dates have been set at this stage
